Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 58630

1.

Validation and reliability of a modified sphygmomanometer for the assessment of handgrip strength in Parkinson´s disease.

Silva SM, Corrêa FI, Silva PF, Silva DF, Lucareli PR, Corrêa JC.

Braz J Phys Ther. 2015 27/04;19(2):137-145. Epub 2015 Apr 27.

2.

Naltrexone for impulse control disorders in Parkinson disease: a placebo-controlled study.

Weintraub D, Papay K, Xie SX.

Neurology. 2015 Mar 31;84(13):1386-7. No abstract available.

PMID:
25992402
3.

Naltrexone for impulse control disorders in Parkinson disease: a placebo-controlled study.

Liang JW, Shanker VL, Groves M.

Neurology. 2015 Mar 31;84(13):1386-7. No abstract available.

PMID:
25992401
4.

Olfaction in neurologic and neurodegenerative diseases: a literature review.

Godoy MD, Voegels RL, Pinna Fde R, Imamura R, Farfel JM.

Int Arch Otorhinolaryngol. 2015 Apr;19(2):176-9. doi: 10.1055/s-0034-1390136. Epub 2014 Nov 14.

PMID:
25992176
5.

What do patients with scans without evidence of dopaminergic deficit (SWEDD) have? New evidence and continuing controversies.

Erro R, Schneider SA, Quinn NP, Bhatia KP.

J Neurol Neurosurg Psychiatry. 2015 May 19. pii: jnnp-2014-310256. doi: 10.1136/jnnp-2014-310256. [Epub ahead of print] Review.

PMID:
25991401
6.

Thinking about motor fluctuations: An examination of metacognitions in Parkinson's disease.

Fernie BA, Spada MM, Ray Chaudhuri K, Klingelhoefer L, Brown RG.

J Psychosom Res. 2015 May 12. pii: S0022-3999(15)00436-5. doi: 10.1016/j.jpsychores.2015.05.001. [Epub ahead of print]

PMID:
25990617
7.

Biomarkers in Parkinson disease: It's time to combine.

McKeown MJ, Peavy GM.

Neurology. 2015 May 15. pii: 10.1212/WNL.0000000000001692. [Epub ahead of print] No abstract available.

PMID:
25979702
8.

CSF proteins and resting-state functional connectivity in Parkinson disease.

Campbell MC, Koller JM, Snyder AZ, Buddhala C, Kotzbauer PT, Perlmutter JS.

Neurology. 2015 May 15. pii: 10.1212/WNL.0000000000001681. [Epub ahead of print]

PMID:
25979701
9.

Approach to the Patient with Parkinson Disease.

Johnson KE.

Prim Care. 2015 Jun;42(2):205-215. doi: 10.1016/j.pop.2015.01.005. Epub 2015 Mar 5. Review.

PMID:
25979582
10.

Computerized analysis of the distribution of occlusal contacts in individuals with Parkinson's disease and temporomandibular disorder.

Silva PF, Motta LJ, Silva SM, Ferrari RA, Fernandes KP, Bussadori SK.

Cranio. 2015 May 15:2151090315Y0000000012. [Epub ahead of print]

PMID:
25979091
11.

Fully automated targeting using nonrigid image registration matches accuracy and exceeds precision of best manual approaches to subthalamic deep brain stimulation targeting in Parkinson disease.

Pallavaram S, DʼHaese PF, Lake W, Konrad PE, Dawant BM, Neimat JS.

Neurosurgery. 2015 Jun;76(6):756-65. doi: 10.1227/NEU.0000000000000714.

PMID:
25988929
12.

A native interactor scaffolds and stabilizes toxic Ataxin-1 oligomers in SCA1.

Lasagna-Reeves CA, Rousseaux MW, Guerrero-Munoz MJ, Park J, Jafar-Nejad P, Richman R, Lu N, Sengupta U, Litvinchuk A, Orr HT, Kayed R, Zoghbi HY.

Elife. 2015 May 19;4. doi: 10.7554/eLife.07558. [Epub ahead of print]

13.

To operate or not?: A literature review of surgical outcomes in 95 patients with Parkinson's disease undergoing spine surgery.

Sarkiss CA, Fogg GA, Skovrlj B, Cho SK, Caridi JM.

Clin Neurol Neurosurg. 2015 May 6;134:122-125. doi: 10.1016/j.clineuro.2015.04.022. [Epub ahead of print] Review.

PMID:
25988602
14.

Mediation of organismal aging and somatic proteostasis by the germline.

Khodakarami A, Saez I, Mels J, Vilchez D.

Front Mol Biosci. 2015 Jan 23;2:3. doi: 10.3389/fmolb.2015.00003. eCollection 2015. Review.

15.

Cytosolic PTEN-INDUCED PUTATIVE KINASE 1 is Stabilized By NF-κB Pathway and Promotes Non-Selective Mitophagy.

Lim GG, Chua DS, Basil AH, Chan HY, Chai C, Arumugam T, Lim KL.

J Biol Chem. 2015 May 18. pii: jbc.M114.622399. [Epub ahead of print]

16.

The emergence of Parkinson disease among patients with Gaucher disease.

Elstein D, Alcalay R, Zimran A.

Best Pract Res Clin Endocrinol Metab. 2015 Mar;29(2):249-259. doi: 10.1016/j.beem.2014.08.007. Epub 2014 Aug 23. Review.

PMID:
25987177
17.

Parkinson bradykinesia correlates with EEG background frequency and perceptual forward projection.

Beudel M, Roosma E, Martinez Manzanera OE, van Laar T, Maurits NM, de Jong BM.

Parkinsonism Relat Disord. 2015 May 6. pii: S1353-8020(15)00201-1. doi: 10.1016/j.parkreldis.2015.05.004. [Epub ahead of print]

PMID:
25986742
18.

Olfactory function combined with morphology distinguishes Parkinson's disease.

Sengoku R, Matsushima S, Bono K, Sakuta K, Yamazaki M, Miyagawa S, Komatsu T, Mitsumura H, Kono Y, Kamiyama T, Ito K, Mochio S, Iguchi Y.

Parkinsonism Relat Disord. 2015 May 11. pii: S1353-8020(15)00197-2. doi: 10.1016/j.parkreldis.2015.05.001. [Epub ahead of print]

PMID:
25986741
19.

The 'parkinsonian heart': a diagnostic and prognostic tool.

Muxí Á.

J Neurol Neurosurg Psychiatry. 2015 May 18. pii: jnnp-2015-310785. doi: 10.1136/jnnp-2015-310785. [Epub ahead of print] No abstract available.

PMID:
25986366
20.

A smaller amygdala is associated with anxiety in Parkinson's disease: a combined FreeSurfer-VBM study.

Vriend C, Boedhoe PS, Rutten S, Berendse HW, van der Werf YD, van den Heuvel OA.

J Neurol Neurosurg Psychiatry. 2015 May 18. pii: jnnp-2015-310383. doi: 10.1136/jnnp-2015-310383. [Epub ahead of print]

PMID:
25986365
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk